Heart Failure Nyha Class Iii Clinical Trials
2 recruiting trials for Heart Failure Nyha Class Iii. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Heart Failure Nyha Class Iii clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Hospital District of Helsinki and Uusimaa (1), Guangdong Provincial Hospital of Traditional Chinese Medicine (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Epicardial AAMs-patch transplantation (procedure, 1 trial), followed by RNA-stabilized whole blood sampling, Plasma sampling.
Track Heart Failure Nyha Class Iii trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery
Ischemic heart disease (IHD) leads the global mortality statistics. Atherosclerotic plaques in coronary arteries hallmark IHD, drive hypoxia, and may rupture to result in...
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
Chronic heart failure (CHF) is a major and growing public health problem and poses economic burden on the society. There is a need for a safe, equipment-free, low-cost, and easily...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Heart Failure Nyha Class Iii, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Heart Failure Nyha Class Iii, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Heart Failure Nyha Class Iii, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.